IOVANCE BIOTHERAPEUTICS, INC. (IOVA) › Total LiabilitiesIOVANCE BIOTHERAPEUTICS, INC. (IOVA) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2017: $9.89M2018: $14.63M2019: $45.68M2020: $111.96M2021: $155.67M2022: $164.34M2023: $195.74M2024: $200.02M2025: $214.59M$214.59M2017Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$214.59M+7.3%2024$200.02M+2.2%2023$195.74M+19.1%2022$164.34M+5.6%2021$155.67M+39.0%2020$111.96M+145.1%2019$45.68M+212.3%2018$14.63M+47.9%2017$9.89M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share